New CRO unit facility welcomes first overnight patients

One month on from Richmond’s opening event, which saw leading industry bodies and stakeholders convene, the CRO has been busy settling in their first patients at the new London Bridge site.

Clinical work commenced on the 25th March with volunteers commenting on the excellent transport links and fantastic new location in the heart of London Bridge.

Testimonials

I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.

- Anonymous

Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.

- Anonymous

Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.

- Anonymous

Latest news

COVID-19 – External Monitoring Guidelines

04th May 2020

Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing

Read more ›

Statement on COVID-19

23rd Mar 2020

Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are

Read more ›

First transdermal patch to treat schizophrenia hits market

18th Mar 2020

The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia

Read more ›

Cardiac Safety London

To help to enrich and speed up your drug development programs, join us for a day of discovery as global experts in

View event ›